Leanne Kelly
CIK 1398278 · Chief Financial Officer · last filed 2025-09-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
12
Lifetime Open-Market Net
$25.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GRI | Chief Financial Officer | — | $2.25 | — | $0 | 4 | 2025-09-22 |
| GRI Bio, Inc. (VLON) Delisted | Chief Financial Officer | 6,250 | $12.00 | $75.0K | $25.2K | 3 | 2022-03-01 |
| GENAERA CORP (GENR) Delisted | SVP & Chief Financial Officer | 2,183 | — | — | $0 | 4 | 2008-08-13 |
| GENAERA CORP (GENRD) Delisted | Sr. Vice President & CFO | — | — | — | $0 | 1 | 2007-05-22 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-05-22 | GENAERA CORP (GENRD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-02 | GENAERA CORP (GENR) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.